These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1335 related articles for article (PubMed ID: 12534314)

  • 1. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
    Stephen LJ
    Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.
    Perucca E
    CNS Drugs; 2002; 16(10):695-714. PubMed ID: 12269862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of drug interactions in epilepsy therapy.
    Patsalos PN; Fröscher W; Pisani F; van Rijn CM
    Epilepsia; 2002 Apr; 43(4):365-85. PubMed ID: 11952767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epilepsy in the elderly.
    Leppik IE
    Epilepsia; 2006; 47 Suppl 1():65-70. PubMed ID: 17044830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard approach to antiepileptic drug treatment in the United States.
    Pellock JM
    Epilepsia; 1994; 35 Suppl 4():S11-8. PubMed ID: 8174515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic management of epilepsy in the elderly.
    Bourdet SV; Gidal BE; Alldredge BK
    J Am Pharm Assoc (Wash); 2001; 41(3):421-36. PubMed ID: 11372907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.
    Eriksson AS; Hoppu K; Nergårdh A; Boreus L
    Epilepsia; 1996 Aug; 37(8):769-73. PubMed ID: 8764817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and adverse effects of established and new antiepileptic drugs.
    Mattson RH
    Epilepsia; 1995; 36 Suppl 2():S13-26. PubMed ID: 8784211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The decreased level of plasma carnitine in patients with epilepsy].
    Belousova ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Oct; 29(4):257-86. PubMed ID: 8549027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
    Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
    BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Riva R; Albani F; Avoni P; Baruzzi A
    Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
    Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH
    Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R; Peters DH; McTavish D
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate as a mainstay of therapy for pediatric epilepsy.
    Guerrini R
    Paediatr Drugs; 2006; 8(2):113-29. PubMed ID: 16608372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
    Ramsay RE; McManus DQ; Guterman A; Briggle TV; Vazquez D; Perchalski R; Yost RA; Wong P
    Ther Drug Monit; 1990 May; 12(3):235-41. PubMed ID: 2112276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.